inclusion criteria: 1. provision of signed and dated informed consent form 2. stated willingness to comply with all study procedures and availability for the duration of the study 3. male or female ≥ 18 years of age 4. patient showing a positive test for sars-cov-2 with \< 26 ct of an fda-approved pcr test who is symptomatic or flu-like illness or pneumonia 5. ability to tolerate an 12-minute non-painful nasal light illumination

inclusion criteria: 1. provision of signed and dated informed consent form 2. stated willingness to comply with all study procedures and availability for the duration of the study 3. male or female ≥ 18 years of age 4. patient showing a positive test for sars-cov-2 with \< 26 ct of an fda-approved pcr test who is symptomatic or flu-like illness or pneumonia 5. ability to tolerate an 12-minute non-painful nasal light illumination

inclusion criteria: provision of signed and dated informed consent form stated willingness to comply with all study procedures and availability for the duration of the study male or female ≥ 18 years of age patient showing a positive test for sars-cov-2 with < 26 ct of an fda-approved pcr test who is symptomatic or flu-like illness or pneumonia ability to tolerate an 12-minute non-painful nasal light illumination

inclusion criteria: provision of signed and dated informed consent form stated willingness to comply with all study procedures and availability for the duration of the study male or female ≥ 18 years of age patient showing a positive test for sars-cov-2 with < 26 ct of an fda-approved pcr test who is symptomatic or flu-like illness or pneumonia ability to tolerate an 12-minute non-painful nasal light illumination